Caja Costarricense de Seguro Social
🇨🇷Costa Rica
- Country
- 🇨🇷Costa Rica
- Ownership
- -
- Established
- 1941-01-01
- Employees
- 53.4K
- Market Cap
- -
- Website
- https://www.ccss.sa.cr/
A Study on Rare Dermatological Infections Conducted at Three Major Reference Hospitals in Costa Rica.
Completed
- Conditions
- BlastomycosisParacoccidioidomycosisPhaeomycosisSporotrichosisChromomycosisMycobacterial Cutaneous InfectionNocardiosisCoccidioidomycosisActinomycosisMycetoma
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Caja Costarricense de Seguro Social
- Target Recruit Count
- 95
- Registration Number
- NCT06523998
- Locations
- 🇨🇷
Hospital México, San José, Costa Rica
🇨🇷Hospital San Juan de Dios, San José, Costa Rica
🇨🇷Hospital Rafael Ángel Calderón Guardia, San José, Costa Rica
Implementation of an Epidemiological and Clinical Registry of Emergency Surgery Patients in a Costa Rican Hospital
Completed
- Conditions
- Surgical ComplicationEmergencies
- First Posted Date
- 2023-07-05
- Last Posted Date
- 2023-07-05
- Lead Sponsor
- Caja Costarricense de Seguro Social
- Target Recruit Count
- 575
- Registration Number
- NCT05930574
- Locations
- 🇨🇷
Unidad de Investigación en Salud, Hospital Dr. Rafael Angel Calderón Guardia, San José, Costa Rica
Primary Immunodeficiencies in Costa Rican Adults
Completed
- Conditions
- Primary Immune Deficiency in Adults
- First Posted Date
- 2021-07-15
- Last Posted Date
- 2021-07-15
- Lead Sponsor
- Caja Costarricense de Seguro Social
- Target Recruit Count
- 137
- Registration Number
- NCT04963660
- Locations
- 🇨🇷
Hospital Calderon Guardia, San José, Costa Rica
Efficacy and Safety of Three Different Doses of an Anti SARS-CoV-2 Hyperimmune Equine Serum in COVID-19 Patients
Phase 2
- Conditions
- Covid19
- Interventions
- Biological: Anti SARS-CoV-2 equine hyperimmune serumBiological: placebo
- First Posted Date
- 2021-04-09
- Last Posted Date
- 2021-05-21
- Lead Sponsor
- Caja Costarricense de Seguro Social
- Target Recruit Count
- 156
- Registration Number
- NCT04838821
- Locations
- 🇨🇷
Centro Especializado de Atención COVID19 (CEACO), San José, Costa Rica
🇨🇷Hospital San Juan de Dios, San José, Costa Rica
🇨🇷Hospital México, San José, Costa Rica
Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients
Phase 2
Completed
- Conditions
- Covid19
- Interventions
- Biological: Administration of Equine immunoglobulin anti SARS-CoV-2
- First Posted Date
- 2020-10-30
- Last Posted Date
- 2021-03-19
- Lead Sponsor
- Caja Costarricense de Seguro Social
- Target Recruit Count
- 26
- Registration Number
- NCT04610502
- Locations
- 🇨🇷
Hospital San Juan de Dios, San José, Costa Rica
🇨🇷Hospital Dr. Rafael Ángel Calderón Guardia, San José, Costa Rica
🇨🇷Centro Especializado de Atención COVID19 (CEACO), San José, Costa Rica
© Copyright 2025. All Rights Reserved by MedPath